Henning Schliephake1, Alberto Sicilia2, Bilal Al Nawas3, Nikos Donos4, Reinhard Gruber5, Søren Jepsen6, Iva Milinkovic7, Andrea Mombelli8, Jose Manuel Navarro9, Marc Quirynen10, Isabella Rocchietta11, Morten Schiødt12, Søren Schou13, Alexandra Stähli14, Andreas Stavropoulos15. 1. Department of Oral & Maxillofacial Surgery, University Medicine George-Augusta-University, Göttingen, Germany. 2. Section of Periodontology, Faculty of Medicine and Health Science, University Clinic of Dentistry, University of Oviedo, Oviedo, Spain. 3. Department of Oral and Maxillofacial Surgery, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany. 4. Lead Centre for Immunobiology & Regenerative Medicine QMUL, Barts and The London School of Medicine & Dentistry, London, UK. 5. Department of Oral Biology, Medical University of Vienna, MedUni Vienna, Vienna, Austria. 6. Department of Periodontology, University of Bonn, Bonn, Germany. 7. Department of Periodontology, School of Dental Medicine, University of Belgrade, Beograd, Serbia. 8. Division of Periodontology, University Clinics of Dental Medicine, University of Geneva, Geneva, Switzerland. 9. Private Practice Harley Street, London, UK. 10. Department of Dentistry, Universitair Ziekenhuis Leuven, Leuven, Belgium. 11. The London Centre for Implant and Aesthetic Dentistry (LCIAD) Ltd, London, UK. 12. Department of Oral & Maxillofacial Surgery, Rigshospitalet, Copenhagen, Denmark. 13. Department of Oral & Maxillofacial Surgery, School of Dentistry, University of Copenhagen, Copenhagen, Denmark. 14. Klinik für Parodontologie, Zahnmedizinische Kliniken Bern, Universität Bern, Bern, Switzerland. 15. Department of Periodontology, Centre of Oral Health Sciences, Faculty of Odontology, Malmö University, Malmö, Sweden.
Abstract
OBJECTIVES: The task of this working group was to update the knowledge about the use of drugs and biologicals affecting healing of soft tissue and bone during implant treatment or procedures associated with it. Moreover, the impact of titanium particles and biocorrosion on complications and implant survival has been analysed. MATERIALS AND METHODS: The literature in the areas of interest (platelet concentrates, antiresorptive drugs as well as implant-host interaction) was screened using systematic reviews for the former two areas, whereas a narrative critical review was performed for the latter topic. Two manuscripts on platelet concentrates, one manuscript on antiresorptive drugs and one manuscript on the effects of biocorrosion, were presented for group analysis with subsequent discussion in the plenum and final consensus approval. RESULTS: Results and conclusions of the individual reviews of the three topics are presented in the respective papers. Conclusions of the group on strengths and weaknesses of available evidence as well as consensus statements and directions for further research are provided in this study. The following papers were subject to group discussions and formed the basis for the consensus statements: Stähli A, Strauss FJ, Gruber R. () The use of platelet-rich-plasma to enhance the outcomes of implant-related therapies: a systematic review Strauss FJ, Stähli A, Gruber R. (2018) The use of platelet-rich-fibrin to enhance the outcomes of implant-related therapies: a systematic review Mombelli A, Hashim D, Cionca N. () What is the impact of titanium particles and bio-corrosion on implant survival and complications? A critical review Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Morten Schiødt, Klinge B. () The effect of antiresorptive drugs on implant therapy: a systematic review.
OBJECTIVES: The task of this working group was to update the knowledge about the use of drugs and biologicals affecting healing of soft tissue and bone during implant treatment or procedures associated with it. Moreover, the impact of titanium particles and biocorrosion on complications and implant survival has been analysed. MATERIALS AND METHODS: The literature in the areas of interest (platelet concentrates, antiresorptive drugs as well as implant-host interaction) was screened using systematic reviews for the former two areas, whereas a narrative critical review was performed for the latter topic. Two manuscripts on platelet concentrates, one manuscript on antiresorptive drugs and one manuscript on the effects of biocorrosion, were presented for group analysis with subsequent discussion in the plenum and final consensus approval. RESULTS: Results and conclusions of the individual reviews of the three topics are presented in the respective papers. Conclusions of the group on strengths and weaknesses of available evidence as well as consensus statements and directions for further research are provided in this study. The following papers were subject to group discussions and formed the basis for the consensus statements: Stähli A, Strauss FJ, Gruber R. () The use of platelet-rich-plasma to enhance the outcomes of implant-related therapies: a systematic review Strauss FJ, Stähli A, Gruber R. (2018) The use of platelet-rich-fibrin to enhance the outcomes of implant-related therapies: a systematic review Mombelli A, Hashim D, Cionca N. () What is the impact of titanium particles and bio-corrosion on implant survival and complications? A critical review Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Morten Schiødt, Klinge B. () The effect of antiresorptive drugs on implant therapy: a systematic review.
Authors: Luca Fiorillo; Gabriele Cervino; Pablo Galindo-Moreno; Alan Scott Herford; Gianrico Spagnuolo; Marco Cicciù Journal: Biomed Res Int Date: 2021-01-06 Impact factor: 3.411
Authors: Achim V Schwartzenberg; Chun Ching Liu; Philipp Sahrmann; Patrick R Schmidlin; Ronald E Jung; Nadja Naenni Journal: Dent J (Basel) Date: 2022-08-29